Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMJGleeson Regulatory News (GLE)

Share Price Information for MJGleeson (GLE)

Share Price is delayed by 15 minutes
Get Live Data
248.50    3.50 (1.43%)
Bid:
249.00
Ask:
251.00
Spread: 2.00 (0.803%)
Market Cap: £144.97m
GLE Live PriceLast checked at - London Stock Exchange

Intraday MJGleeson Share Chart

Trading Update

2 Jul 2013 07:00

RNS Number : 3399I
Gleeson(M J)Group PLC
02 July 2013
Β 

ο»Ώ

Β 

2 July 2012

Β 

MJ GLEESON GROUP PLC

TRADING UPDATE

Β 

MJ Gleeson Group plc (GLE.L), the urban regeneration and strategic land specialist, is today issuing the following trading update following the end of its financial year on 30 June.

Β 

Gleeson Homes

Β 

Gleeson Homes sold 406 homes during the year, an increase of 44% compared with the previous year's total of 279. The proportion of units sold on recently acquired, higher margin sites improved significantly compared to the prior year. Of the units sold, 75% were from the higher margin sites compared to last year's 31%. The higher proportion of profitable units sold, along with the increase in the volume of sales, substantially improved the profitability of the business unit for the year.

Β 

During the year Gleeson Homes remained very active in purchasing and starting on sites. On 30 June it had 34 open sites, compared to 28 sites at the commencement of the year. The landbank of plots at the year-end comprised 3,868 plots of which 1,240 plots are conditionally purchased. In addition, there are a further 2,000 plots which are in the pipeline to be acquired.

Β 

The forward order book for Gleeson Homes at 1 July 2013 totalled Β£25.9m representing 221 homes, an improvement of 141% on last year's total of Β£10.8m.

Β 

Gleeson Strategic Land

Β 

Gleeson Strategic Land continues to take advantage of the strong demand for green field residential land in the South of England from the major housebuilders.

Β 

During the year Gleeson Strategic Land disposed of seven sites on which it had obtained residential planning consents. These comprised 42.5 acres and delivered 439 plots for development. The disposals occurred in the business unit's core area of activity of Southern England.

Β 

The land portfolio continued to be replenished with good quality opportunities. Gleeson Strategic Land secured new option or promotion agreements on ten sites, comprising 203 acres with the potential to deliver a further 1,200 plots. A number of these new sites will be the subject of immediate planning applications and therefore have the potential to deliver profit in the short term.

Β 

Trading Performance

Β 

The Group will deliver a level of profitability from the business units for the year ending 30 June 2013, materially ahead of market expectations. In addition to the strong trading performances of the business units, the Group will be recording an exceptional credit arising from the sale of its last remaining PFI investment, as previously announced, and the expected release of a prior year provision.

Β 

The Group continues to be in a strong cash position with cash balances at 30 June 2013 of Β£9.7m.

Β 

Β 

The Group plans to announce its preliminary results on Friday 27 September 2013.

Β 

Β 

Enquiries:

Β 

M J Gleeson Group plc

Jolyon Harrison Chief Executive Officer 0114 261 2900

Alan Martin Chief Financial Officer 01252 360 300

Β 

Β 

Notes to Editors

Β 

MJ Gleeson Group plc operates in the house building sector through the following business units; Gleeson Homes, which focuses on estate regeneration and housing development on brownfield land in the North of England; and Gleeson Strategic Land, which purchases options over land in the South of England with the objective of enhancing the value of the site concerned by securing residential planning permission.

Β 

Β 

This information is provided by RNS
The company news service from the London Stock Exchange
Β 
END
Β 
Β 
TSTSSIFMFFDSEEW
Date   Source Headline
30th Nov 20237:00 amRNSTotal Voting Rights
27th Nov 20234:29 pmRNSDirector/PDMR Shareholding
16th Nov 20231:33 pmRNSResult of AGM
16th Nov 20237:00 amRNSAGM Trading Update
8th Nov 20233:29 pmRNSDirector/PDMR Shareholding
31st Oct 20237:00 amRNSTotal Voting Rights
24th Oct 20234:17 pmRNSDirector/PDMR Shareholding
23rd Oct 20231:56 pmRNSExercise of Options & Director/ PDMR Dealing
17th Oct 20237:00 amRNSNotice of AGM
6th Oct 20232:37 pmRNSDirector/PDMR Shareholding
29th Sep 20237:00 amRNSTotal Voting Rights
27th Sep 20234:17 pmRNSExercise of Options & PDMR Dealing
26th Sep 20234:38 pmRNSDirector/PDMR Shareholding
15th Sep 20233:54 pmRNSDirector/PDMR Shareholding
15th Sep 202310:35 amRNSDirector/PDMR Shareholding
14th Sep 20234:41 pmRNSDirector/PDMR Shareholding
14th Sep 20237:00 amRNSAudited results for the year ended 30 June 2023
7th Sep 202312:20 pmRNSDirector/PDMR Shareholding
31st Aug 20237:00 amRNSTotal Voting Rights
8th Aug 20234:55 pmRNSDirector/PDMR Shareholding
31st Jul 20237:00 amRNSTotal Voting Rights
7th Jul 20233:48 pmRNSDirector/PDMR Shareholding
7th Jul 20237:00 amRNSTrading Update and Capital Markets Day
30th Jun 20237:00 amRNSSale of portfolio of homes to Carlyle
30th Jun 20237:00 amRNSTotal Voting Rights
8th Jun 20232:23 pmRNSDirector/PDMR Shareholding
31st May 20237:00 amRNSTotal Voting Rights
15th May 20233:30 pmRNSHolding(s) in Company
10th May 20231:56 pmRNSDirector/PDMR Shareholding
28th Apr 20237:00 amRNSTotal Voting Rights
14th Apr 202310:01 amRNSDirector/PDMR Shareholding
6th Apr 202311:13 amRNSDirector/PDMR Shareholding
5th Apr 20234:37 pmRNSDirector/PDMR Shareholding
31st Mar 20237:00 amRNSTotal Voting Rights
29th Mar 20237:00 amRNSDirector/PDMR Shareholding
24th Mar 20237:00 amRNSRe Directorate
21st Mar 20237:00 amRNSNotice of Capital Markets Day and Trading Update
13th Mar 20233:58 pmRNSSigning of the Self-Remediation Terms
8th Mar 20235:13 pmRNSDirector/PDMR Shareholding
28th Feb 20237:00 amRNSTotal Voting Rights
27th Feb 202312:05 pmRNSPerformance Share Plan award to Directors & PDMRs
16th Feb 20237:00 amRNSResults for the half-year ended 31 December 2022
8th Feb 20235:18 pmRNSCommittee appointments
8th Feb 20231:45 pmRNSDirector/PDMR Shareholding
31st Jan 20237:00 amRNSTotal Voting Rights
13th Jan 20237:00 amRNSTrading Update & Notice of Results
6th Jan 20234:42 pmRNSDirector/PDMR Shareholding
3rd Jan 20237:00 amRNSRe Directorate
30th Dec 20227:00 amRNSTotal Voting Rights
15th Dec 202211:06 amRNSDirectorate External Appointments

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.